PT829540E - Parasitas que infectam macrofagos que expressam um factor estimulador de colonias de macrofagos granulocitos - Google Patents

Parasitas que infectam macrofagos que expressam um factor estimulador de colonias de macrofagos granulocitos

Info

Publication number
PT829540E
PT829540E PT97307081T PT97307081T PT829540E PT 829540 E PT829540 E PT 829540E PT 97307081 T PT97307081 T PT 97307081T PT 97307081 T PT97307081 T PT 97307081T PT 829540 E PT829540 E PT 829540E
Authority
PT
Portugal
Prior art keywords
macrofagos
parasites
infect
granulocitos
colonies
Prior art date
Application number
PT97307081T
Other languages
English (en)
Inventor
Marc Ouellette
Barbara Papadopoulou
Martin Olivier
Original Assignee
Univ Laval
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Laval filed Critical Univ Laval
Publication of PT829540E publication Critical patent/PT829540E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT97307081T 1996-09-13 1997-09-12 Parasitas que infectam macrofagos que expressam um factor estimulador de colonias de macrofagos granulocitos PT829540E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/713,768 US6331304B1 (en) 1996-09-13 1996-09-13 Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulating factor

Publications (1)

Publication Number Publication Date
PT829540E true PT829540E (pt) 2002-05-31

Family

ID=24867467

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97307081T PT829540E (pt) 1996-09-13 1997-09-12 Parasitas que infectam macrofagos que expressam um factor estimulador de colonias de macrofagos granulocitos

Country Status (8)

Country Link
US (1) US6331304B1 (pt)
EP (1) EP0829540B1 (pt)
AT (1) ATE209253T1 (pt)
CA (1) CA2215641C (pt)
DE (1) DE69708425T2 (pt)
DK (1) DK0829540T3 (pt)
ES (1) ES2168583T3 (pt)
PT (1) PT829540E (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855537B1 (en) * 1996-09-13 2005-02-15 Aventis Pasteur Limited Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulated factor
GB9706930D0 (en) * 1997-04-04 1997-05-21 Univ Glasgow Leishmania vaccine
US6368827B1 (en) * 1998-12-02 2002-04-09 The University Of Georgia Research Foundation, Inc. Kinetoplastid protein expression system and methods
US20010010928A1 (en) * 1999-03-26 2001-08-02 Stephen M. Beverley Protozoan expression system
WO2002090556A1 (en) * 2001-05-08 2002-11-14 Jena Bioscience Gmbh Method for targeted homologous gene replacement in kinetoplastidae

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT716697E (pt) * 1993-09-03 2003-08-29 Univ Mcgill Genes e proteinas de leishmania expressos diferencialmente

Also Published As

Publication number Publication date
ATE209253T1 (de) 2001-12-15
DK0829540T3 (da) 2002-05-21
ES2168583T3 (es) 2002-06-16
EP0829540A1 (en) 1998-03-18
DE69708425D1 (de) 2002-01-03
DE69708425T2 (de) 2002-05-23
EP0829540B1 (en) 2001-11-21
CA2215641A1 (en) 1998-03-13
US6331304B1 (en) 2001-12-18
CA2215641C (en) 2009-07-07

Similar Documents

Publication Publication Date Title
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
WO2001068077A3 (en) Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
BR0014408A (pt) Antìgenos do vìrus do herpes simples imunologicamente significativos; e métodos para identificação e utilização dos mesmos
DE60023300D1 (de) Verwendung von cpg als adjuvans für hivimpstoff
AU7242796A (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
PT829540E (pt) Parasitas que infectam macrofagos que expressam um factor estimulador de colonias de macrofagos granulocitos
ATE290548T1 (de) Expressionsblockierung von virulenten faktoren in s. aureus
ZA964679B (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
EP0806476A3 (en) Attenuated strains of leishmania and uses thereof
MXPA02010173A (es) Antigenos de leishmania para utilizarse en la terapia y el diagnostico de leishmaniasis.
DE3579617D1 (de) Lebender gereinigter impfstoff gegen die marek'sche krankheit.
YU65102A (sh) In ovo zaštita protiv infektivnog bronhitisa
CA2243730A1 (en) Streptococcus equi vaccine
WO1998035045A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
PT642796E (pt) Vacina viva de salmonella
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
WO2002067984A3 (en) Materials and methods for detecting, preventing, and treating hiv and fiv retroviral infection
Klein et al. Protection against establishment of latent infections in mice immunized with a non-pathogenic herpes simplex virus mutant and reinfected with the pathogenic parental strain
Pal et al. Herpes simiae: A life threatening viral anthropozoonotic disease
WO2023154781A3 (en) Sars-cov-2 vaccine for the prevention and treatment of coronavirus disease (covid-19)
WO2002003061A3 (de) Verfahren zur identifizierung von die für behandlung von virusinfektionen geeigneten stoffen
WO2003093415A3 (en) Methods useful in treatment and prevention of hiv infection
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection